Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation and Depletion: 2019-2025

Historic Depreciation and Depletion for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $900,000.

  • Biodesix's Depreciation and Depletion fell 10.00% to $900,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 12.94%. This contributed to the annual value of $3.8 million for FY2024, which is 179.93% up from last year.
  • Latest data reveals that Biodesix reported Depreciation and Depletion of $900,000 as of Q3 2025, which was down 0.00% from $900,000 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Depreciation and Depletion ranged from a high of $1.0 million in Q3 2024 and a low of $200,000 during Q2 2021.
  • In the last 3 years, Biodesix's Depreciation and Depletion had a median value of $900,000 in 2025 and averaged $710,000.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first fell by 25.00% in 2023, then surged by 233.33% in 2024.
  • Over the past 5 years, Biodesix's Depreciation and Depletion (Quarterly) stood at $428,000 in 2021, then declined by 1.40% to $422,000 in 2022, then grew by 5.45% to $445,000 in 2023, then skyrocketed by 116.85% to $965,000 in 2024, then dropped by 10.00% to $900,000 in 2025.
  • Its last three reported values are $900,000 in Q3 2025, $900,000 for Q2 2025, and $900,000 during Q1 2025.